PHOENIX BIOTECH ACQUISITION
CUSIP 71902K204
Phoenix Biotech Acquisition has 4 institutional holders in Filings Flow’s 13F database, together reporting 110.4K shares worth $1M as of Q4 2022. The largest reported holders are Yakira Capital Management, Inc., Clear Street LLC, and Tower Research Capital LLC (Trc).
Institutional Holders
4
Q4 2022
Reported Value
$1M
Ticker
unmapped
private placement or foreign
Quarters Tracked
2
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Yakira Capital Management, Inc.$342M AUM | 0.27% | $1M | 100.0K | Q1 2023OLDER |
| CLEAR STREET LLC$25.1B AUM | 0.00% | $4,000 | 342 | Q4 2023 |
| Tower Research Capital LLC (TRC)$3.8B AUM | 0.00% | $1,874 | 175 | Q4 2023 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.